# TISSARA Trial: Ticagrelor Intervention to Reduce Stent Thrombosis and Acute MI Risk

> **NCT06667349** · PHASE4 · COMPLETED · sponsor: **National Institute of Cardiovascular Diseases, Pakistan** · enrollment: 1727 (actual)

## Conditions studied

- STEMI - ST Elevation Myocardial Infarction
- Stent Thrombosis
- Antiplatelet Agents

## Interventions

- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT06667349
- **Lead sponsor:** National Institute of Cardiovascular Diseases, Pakistan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-24
- **Primary completion:** 2024-03-03
- **Final completion:** 2024-06-16
- **Target enrollment:** 1727 (ACTUAL)
- **Last updated:** 2024-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06667349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06667349, "TISSARA Trial: Ticagrelor Intervention to Reduce Stent Thrombosis and Acute MI Risk". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06667349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*